Skip to main content
Equibles

Bank of New York Mellon Corp

Bank

Position in LXEO — Lexeo Therapeutics, Inc.

CIK 1390777 NEW YORK, NY
Back to LXEO Full portfolio

Position in LXEO

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$855,974
-$56,105 QoQ
Shares Held
183,883
+15.7% QoQ
Ownership
0.224%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#43
of 141 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority Sole 87% Shared 0% None 13%

Common Shares in LXEO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Bank of New York Mellon Corp holds $4,864,365,655 across 311 Biotechnology names. LXEO ranks #205 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,672,623 $830,842,010
2 REGN
Regeneron Pharmaceuticals, Inc.
 758,492 $472,950,091
3 JAZZ
Jazz Pharmaceuticals plc
 1,578,013 $380,253,782
4 ALNY
Alnylam Pharmaceuticals, Inc.
 492,071 $148,128,128
5 INSM
INSMED Inc
 1,312,756 $139,966,036
6 MRNA
Moderna, Inc.
 1,701,675 $119,168,293
7 RVMD
Revolution Medicines, Inc.
 601,056 $112,565,759
8 INCY
Incyte Corp
 972,825 $110,279,435

All Filings in LXEO

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $855,974 183,883
2026-03-31 $912,079 158,899
2025-12-31 $1,655,815 166,749
2025-09-30 $475,933 71,677
2025-06-30 $261,909 65,152
2025-03-31 $175,734 50,644
2024-12-31 $333,342 50,660
2024-09-30 $433,765 47,983
2024-06-30 $510,168 31,806
2024-03-31 $444,103 28,323
2023-12-31 $189,356 14,110